CN101429204B - (3aS,4S,6aR)-4-(5'-oxohexyl)-tetrahydrothiophen-3, 6-and-imidazolin-2-one and its synthesis method - Google Patents

(3aS,4S,6aR)-4-(5'-oxohexyl)-tetrahydrothiophen-3, 6-and-imidazolin-2-one and its synthesis method Download PDF

Info

Publication number
CN101429204B
CN101429204B CN2007101565625A CN200710156562A CN101429204B CN 101429204 B CN101429204 B CN 101429204B CN 2007101565625 A CN2007101565625 A CN 2007101565625A CN 200710156562 A CN200710156562 A CN 200710156562A CN 101429204 B CN101429204 B CN 101429204B
Authority
CN
China
Prior art keywords
cooled
normal temperature
solution
sodium
temperature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2007101565625A
Other languages
Chinese (zh)
Other versions
CN101429204A (en
Inventor
陈建辉
吴志刚
陈钢
顾立新
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang Medicine Co Ltd Xinchang Pharmaceutical Factory
Original Assignee
Zhejiang Medicine Co Ltd Xinchang Pharmaceutical Factory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang Medicine Co Ltd Xinchang Pharmaceutical Factory filed Critical Zhejiang Medicine Co Ltd Xinchang Pharmaceutical Factory
Priority to CN2007101565625A priority Critical patent/CN101429204B/en
Publication of CN101429204A publication Critical patent/CN101429204A/en
Application granted granted Critical
Publication of CN101429204B publication Critical patent/CN101429204B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

The invention discloses a novel substance, namely (3aS,4S,6aR)-4-(5'-oxohexyl)- tetrahydrothiophene-[3,6-b]imidazoline-2-ketone and a synthesis method thereof. The method for preparing the novel substance comprises the following steps: under the protection of nitrogen, acetylacetic ether is dripped into sodium hydride, sodium alkoxide or metal sodium and an anhydrous solvent, the temperature is increased to be between 100 and 110 DEG C, and a reaction system is clarified and cooled to normal temperature; then sulfonium salt is added into the solution for a thermal insulation reaction at a temperature of between 70 and 90 DEG C, and then the solution is cooled to normal temperature; an organic layer is separated out, a yellowish liquid is obtained through vacuum recovery, then a hydrogen bromide solution is directly added into the yellowish liquid to be heated to reflux, and then the solution is cooled to normal temperature; and a white solid, namely a target product is obtained through the post-treatment. The novel substance provides the comparison of impurities in a pure product for the measurement of impurity content in biotin, thereby improving the quality of the biotin.

Description

(3aS, 4S, 6aR)-4-(5 '-oxo-hexyl)-tetrahydrochysene thiophene phenol-[3,6-is also] tetrahydroglyoxaline-2-ketone and synthetic method thereof
Technical field
The invention discloses the impurity that produces in a kind of d-vitamin H building-up process (3aS, 4S, 6aR)-4-(5 '-oxo-hexyl)-tetramethylene sulfide-[3,6-is also] tetrahydroglyoxaline-2-ketone and synthetic method thereof.
Background technology
The d-vitamin H (d-Biotin) claim vitamin H or vitamin H again, and with free or be distributed widely in the vegeto-animal tissue with the form of protein bound, vitamin H has been widely used in nutrition and the fodder additives aspect of medicine, poultry, domestic animal.Relatively authority's vitamin H quality standard is European Pharmacopoeia EP.2005.1073 at present, and it has proposed the TLC control of 5 related substances (impurity A, B, C, D, E).Because the specificity of vitamin H production technique can produce plurality of impurities in process of production, the existence of impurity directly has influence on the quality of vitamin H product.
Summary of the invention
The purpose of this invention is to provide the impurity that a kind of vitamin H produces in producing (3aS, 4S, 6aR)-4-(5 '-oxo-hexyl)-tetramethylene sulfide-[3,6-is also] tetrahydroglyoxaline-2-ketone, should pure product impurity product in contrast, thereby the content of impurity in the control vitamin H improves the quality of vitamin H.
By the process analysis to vitamin H, because the specificity of its production technique, we pass through impurity enriched, found new impurity (3aS, 4S, 6aR)-4-(5 '-oxo-hexyl)-tetramethylene sulfide-[3,6-is also] tetrahydroglyoxaline-2-ketone (1), its structural formula is as follows:
Figure DEST_PATH_GSB00000238195400021
That another object of the present invention provides is a kind of (3aS, 4S, 6aR)-and the synthetic method of 4-(5 '-oxo-hexyl)-tetramethylene sulfide-[3,6-is also] tetrahydroglyoxaline-2-ketone, it adopts following technical scheme:
(3aS, 4S, 6aR)-4-(5 '-oxo-hexyl)-tetramethylene sulfide-[3,6-is also] synthetic method of tetrahydroglyoxaline-2-ketone, its step is as follows: under the drying nitrogen protection, drip methyl aceto acetate in sodium hydride, sodium alkoxide (sodium methylate or sodium ethylate) or sodium Metal 99.5 and anhydrous solvent, be warming up to 100-110 ℃, make the reaction system clarification, be cooled to normal temperature; Then in above-mentioned solution, add sulfosalt, carry out insulation reaction, be cooled to normal temperature afterwards at 70-90 ℃; With the pH value that gained solution is regulated in acid, tell organic layer, reclaim under reduced pressure gets weak yellow liquid, directly drops into hydrogen bromide solution afterwards, and heat temperature raising is cooled to normal temperature afterwards to refluxing; Add stirring solvent at last, heat up, divide the layer that deoils while hot, reclaim under reduced pressure sour water layer adds dehydrated alcohol, separates out white solid, is target product, and mp:153.2-155.8 ℃, structure is through IR, MS, NMR, HMBS and hsqc spectrum conclusive evidence.The route of above-mentioned synthetic method is as follows:
Synthetic route
Above-mentioned synthetic method, the pH value is controlled at 1-2; Solvent is toluene or dimethylbenzene; Acid is hydrochloric acid or sulfuric acid; Temperature during reflux is controlled at 120 ℃-130 ℃.
The present invention obtain (3aS, 4S 6aR)-4-(5 '-oxo-hexyl)-tetramethylene sulfide-[3,6-also] tetrahydroglyoxaline-2-ketone, for the dirt content test in the vitamin H provides pure product impurity comparison, have improved the quality of vitamin H.
Below in conjunction with embodiment the present invention is done into-goes on foot explanation.
Embodiment
Embodiment 1
Taking back the stream prolong, balance minim pipette, stirring arm; thermometer in the 250ml four-hole boiling flask of drying nitrogen protection, adds sodium hydride 2g; dry toluene 100ml drips methyl aceto acetate 39g (0.3mol) below 40 ℃, be warming up to 100-110 ℃; make the reaction system clarification, be cooled to normal temperature, add sulfosalt (2) 15g (0.0337mol); heat up, control 70-90 ℃ of insulation reaction 6hr, be cooled to normal temperature; sulfuric acid with 10% is regulated pH=1; tell organic layer, water layer divides reextraction with toluene 30ml, merges organic layer; sodium bicarbonate aqueous solution 20ml washing organic layer secondary with 5%; reclaim under reduced pressure gets weak yellow liquid, directly drops into 48%HBr100ml heat temperature raising to 126 ℃, refluxes 4 hours; be cooled to room temperature; add toluene 50ml and stir, be warming up to more than 90 ℃, divide the layer that deoils while hot; reclaim under reduced pressure is the sour water layer to the greatest extent; add dehydrated alcohol 50ml, separate out white solid 7.2g, yield 88%; it is 95% that HPLC measures its content, mp:153.2-155.8 ℃.
From the carbon spectrum and the hsqc spectrum of product 1, can find out has 11 carbon in the molecule, and wherein 2 is quaternary carbon, 3 CH, 5 CH 2, 1 CH 3Its hydrogen spectrum shows in the molecule that 18 hydrogen are arranged, and compares one group of hydrogen signal with the hydrogen spectrum of vitamin H: and δ H6.01 (1H, s), δ H5.65 (1H, s), δ H4.51 (1H, m), δ H4.31 (1H, m) δ H3.16 (1H, m) δ H2.91 (1H, dd, J=5.0HZ, J=13.0HZ), δ H2.74 (1H, d, J=12.4HZ), in conjunction with in the infrared spectrum 3289, there is absorption peak at the 1697cm-1 place, can infer to have the vitamin H mother nucleus structure in the molecule.ESIMS prompting molecular weight is 242, thereby may molecular formula be C 11H 18O 2N 2S.In CNMR, be positioned at δ C201.1 place and show a quaternary carbon signal, can belong to according to its chemical shift and be carbonyl carbon, remove above-mentioned functional group, also have 4 CH in the molecule 2With 1 CH 3, according to CH 3Chemical shift, can infer sorrowful chain is methyl butyl ketone.
By anatomizing its carbon spectrum, hydrogen is composed, and HMBS and hsqc spectrum belong to its each hydrocarbon signal, see Table 1.
Table 1: compound 1 carbon spectrum, hydrogen spectrum and HMBS spectrum data (CDCl 3)
Numbering δC? δH? HMBC?
2? 163.7(C)? /? H-3a,H-6a,N-H?
3a? 61.7(CH)? 4.31(1H,m)? H-6,H-1’,H-3’,N-H?
4? 55.4(CH)? 3.16(1H,m)? H-3a,H-6a,H-1’,H-2’,H-3’,H-6?
6? 40.5(CH2)? 2.91(1H,dd,J=5.0HZ,J=13.0HZ)2.74(1H,d,J=12.4HZ)? H-3?a,H-6a?
6a? 60.1(CH)? 4.51(1H,m)? H-6,H-H?
1’? 28.4(CH2)? 1.78(2H,m)? H-4,H-2’,H-3’?
2’? 28.4(CH2)? 1.47(2H,m)? H-4,H-1’,H-3’,H-4’?
3’? 23.6(CH2)? 1.78(2H,m)? H-1’,H-3’,H-4’,H-6’?
4’? 43.3(CH2)? 2.46(2H,m)? H-1’,H-2’,H-3’,H-6’?
5’? 209.1(C)? /? H-1’,H-3’,H-4’,H-6’?
6’? 29.9(CH3)? 2.14(3H,s)? /?
Embodiment 2
Taking back the stream prolong, balance minim pipette, stirring arm; thermometer in the 250ml four-hole boiling flask of drying nitrogen protection, adds sodium methylate 2.5g; dry toluene 100ml is warming up to 100-110 ℃ time and heats up in a steamer, and drips methyl aceto acetate 39g (0.3mol); drip Bi Baowen and refluxed 1 hour, be cooled to normal temperature, add sulfosalt (2) 15g (0.0337mol); heating and heat preservation back flow reaction 3hr; be cooled to normal temperature, regulate pH=1, tell organic layer with 1N hydrochloric acid; water layer divides reextraction with toluene 30ml; merge organic layer, reclaim under reduced pressure gets weak yellow liquid, directly drops into 48%HBr100ml heat temperature raising to 126 ℃; refluxed 4 hours; be cooled to room temperature, add toluene 50ml and stir, be warming up to more than 90 ℃; divide the layer that deoils while hot; reclaim under reduced pressure is the sour water layer to the greatest extent, adds anhydrous methanol 50ml, separates out white solid 6.5g; yield 79%; it is 92% that HPLC measures its content, and mp:153.2-155.8 ℃ is same target compound after testing.
Embodiment 3
Taking back the stream prolong, balance minim pipette, stirring arm; thermometer in the 250ml four-hole boiling flask of drying nitrogen protection, adds sodium Metal 99.5 1.5g; dry toluene 100ml is warming up to 100-110 ℃ time and heats up in a steamer, and drips methyl aceto acetate 39g (0.3mol); drip Bi Baowen and refluxed 1 hour, be cooled to normal temperature, add sulfosalt 15g (0.0337mol); heating and heat preservation back flow reaction 1hr is cooled to normal temperature, regulates pH=1 with 1N hydrochloric acid; tell organic layer; reclaim under reduced pressure gets weak yellow liquid, directly drops into 48%HBr150ml heat temperature raising to 126 ℃, refluxes 3 hours; be cooled to room temperature; add toluene 50ml and stir, be warming up to more than 90 ℃, divide the layer that deoils while hot; reclaim under reduced pressure is the sour water layer to the greatest extent; add anhydrous methanol 50ml, separate out white solid 6g, yield 74%; it is 90% that HPLC measures its content, is same target compound after testing.
The above only is preferred embodiment of the present invention.Every foundation technical spirit of the present invention all falls within the scope of protection of the present invention any simple modification, equivalent variations and modification that above embodiment did.

Claims (3)

1. (3aS, 4S, 6aR)-and 4-(5 '-oxo-hexyl)-tetramethylene sulfide-[3,6-is also] tetrahydroglyoxaline-2-ketone, its structural formula is as follows:
Figure FSB00000238195300011
2. according to the synthetic method of the described compound of claim 1, its step is as follows: under nitrogen protection, drip methyl aceto acetate in sodium hydride, sodium alkoxide or sodium Metal 99.5 and dry toluene or anhydrous dimethyl benzene, be warming up to 100-110 ℃, make the reaction system clarification, be cooled to normal temperature afterwards; Then in the above-mentioned solution adding (8bS)-1,3-dibenzyl-2-oxo-decahydro imidazoles [3,4-d] thieno-[1,2-a] sulfonium bromide carries out insulation reaction at 70-90 ℃, is cooled to normal temperature afterwards for 3aR, 8aS; The pH value of regulating gained solution with hydrochloric acid or sulfuric acid is told organic layer at 1-2, and reclaim under reduced pressure gets weak yellow liquid, directly drops into hydrogen bromide solution afterwards, is heated to backflow, is cooled to normal temperature afterwards; The back adds toluene or dimethylbenzene stirring again, heats up, and divides the layer that deoils while hot, and reclaim under reduced pressure sour water layer adds dehydrated alcohol, separates out white solid, is target product.
3. according to the synthetic method of the described compound of claim 2, the temperature when it is characterized in that refluxing is controlled at 120 ℃-130 ℃.
CN2007101565625A 2007-11-08 2007-11-08 (3aS,4S,6aR)-4-(5'-oxohexyl)-tetrahydrothiophen-3, 6-and-imidazolin-2-one and its synthesis method Expired - Fee Related CN101429204B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2007101565625A CN101429204B (en) 2007-11-08 2007-11-08 (3aS,4S,6aR)-4-(5'-oxohexyl)-tetrahydrothiophen-3, 6-and-imidazolin-2-one and its synthesis method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2007101565625A CN101429204B (en) 2007-11-08 2007-11-08 (3aS,4S,6aR)-4-(5'-oxohexyl)-tetrahydrothiophen-3, 6-and-imidazolin-2-one and its synthesis method

Publications (2)

Publication Number Publication Date
CN101429204A CN101429204A (en) 2009-05-13
CN101429204B true CN101429204B (en) 2010-12-29

Family

ID=40644867

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2007101565625A Expired - Fee Related CN101429204B (en) 2007-11-08 2007-11-08 (3aS,4S,6aR)-4-(5'-oxohexyl)-tetrahydrothiophen-3, 6-and-imidazolin-2-one and its synthesis method

Country Status (1)

Country Link
CN (1) CN101429204B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1564813A (en) * 2001-12-04 2005-01-12 田边制药株式会社 Intermediate for biotin and process for producing the same
CN1616463A (en) * 2003-11-10 2005-05-18 浙江医药股份有限公司新昌制药厂 Process for preparing dibenzyl biotin
CN1778803A (en) * 2004-11-17 2006-05-31 上海迪赛诺维生素有限公司 Production of d-biotin

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1564813A (en) * 2001-12-04 2005-01-12 田边制药株式会社 Intermediate for biotin and process for producing the same
CN1616463A (en) * 2003-11-10 2005-05-18 浙江医药股份有限公司新昌制药厂 Process for preparing dibenzyl biotin
CN1778803A (en) * 2004-11-17 2006-05-31 上海迪赛诺维生素有限公司 Production of d-biotin

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
陈芬儿等.d生物素的不对称全合成研究.药学学报.1999,第34卷(第11期),第822-827页. *

Also Published As

Publication number Publication date
CN101429204A (en) 2009-05-13

Similar Documents

Publication Publication Date Title
CN104496983B (en) A kind of preparation method of Pa Boxini
PH12014000375B1 (en) New thienopyrimidine derivatives, a process for their preparation and pharmaceutical compositions containing them
CN105481925B (en) A kind of preparation method of Austria's shellfish cholic acid and its intermediate
CN104130258B (en) The method for transformation of a kind of dimer
CN106188062A (en) Replace the preparation method of Buddhist nun according to Shandong, replace intermediate and the preparation method of intermediate of Buddhist nun according to Shandong
CN101429204B (en) (3aS,4S,6aR)-4-(5'-oxohexyl)-tetrahydrothiophen-3, 6-and-imidazolin-2-one and its synthesis method
CN102702191A (en) Synthesis method of vinpocetine
CN108840868B (en) The preparation method and application of trypoline ketone compounds with anti-tumor activity
CN103772189B (en) Synthesis method of diethylstilbestrol compound methyl pigeon pea ketonic acid A
CN109438448A (en) A kind of indoles and compounds with 7-member cycle and its preparation method and application
CN110498744A (en) A kind of preparation method of 1- ethyl -3- nitrobenzene
CN104945458B (en) A kind of synthetic method of progesterone
CN104003946A (en) Preparation method for erlotinib hydrochloride impurity
CN113195454B (en) Preparation method of amide-like derivative and intermediate thereof
CN109422698B (en) Preparation method of amine compound
CN103992298B (en) The method of synthesis 3-styrylcoumarin compounds
BRPI0911622B1 (en) DERIVATIVES OF BENZOXEPINE AND BENZOCYCLOHEPTAN, THEIR PREPARATION PROCESS, THEIR USE AND PHARMACEUTICAL COMPOSITION INCLUDING THEM
CN101555248B (en) Method for preparing poly-substituted 1, 5-naphthyridine compound
CN101429206B (en) Hexa-hydrogen-1-sulpho-3, 4-diaza-cyclopentane[cd]indene-4-ketone and synthesis thereof
CN105968108B (en) A kind of method for synthesizing Pabuk former times profit cloth intermediate
CN103864730B (en) The preparation technology of Telbivudine key intermediate
CN106496263B (en) Process for producing hexahydrofurofuranol derivative, intermediate therefor, and process for producing the intermediate
CN106518826A (en) High-selectivity preparation method for 7-methoxy-6/8-hydroxy coumarin
CN102702192A (en) Synthesis method of vinpocetine
CN103570781A (en) Industrialized preparation method for capecitabine

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20101229

Termination date: 20151108

EXPY Termination of patent right or utility model